SCHEMBL6700459

SCHEMBL6700459

O=C1NS(=O)(=O)c2c1ccc(S(=O)(=O)O)c2S(=O)(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 11/20 0.40
CA9 Q16790 11/20 0.40
CA2 P00918 9/20 0.40
CA7 P43166 5/20 0.40
CA1 P00915 4/20 0.40
GLO1 Q04760 1/20 0.40
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
BCHE P06276 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
KMT2A Q03164 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
CHEK1 O14757 1/20 0.33
DAPK3 O43293 1/20 0.33
MAP4K4 O95819 1/20 0.33
RET P07949 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6699520 0.80 CA12 (0.44) CA12CA9CA2CA7CA1
SCHEMBL10921837 0.71 TSHR (0.41) KDM4ELMNA
SCHEMBL6700624 0.68 RET (0.30) RETGRK5TYRO3DYRK1B
SCHEMBL230481 0.65 CA9 (0.50) CA12CA9CA2CA7CA1
SCHEMBL2804664 0.65 RET (0.44) CA12CA9CA2CA7CA1
SCHEMBL27715076 0.63 CHEK1 (0.56) CA12CA9CA2CA7CA1
SCHEMBL7100055 0.63 CA12 (0.41) CA12CA9CA2CA7CA1
Saccharin SCHEMBL3661332 0.63 CA12 (0.81) CA12CA9CA2CA7CA1
Saccharin SCHEMBL10380910 0.63 CA12 (0.81) CA12CA9CA2CA7CA1
Saccharin SCHEMBL299663 0.63 CA12 (0.81) CA12CA9CA2CA7CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040137082-A1 Compounds and methods for reducing myostatin concentration PHOENIX LABORATORIES INC 2004-07-15 US claimed
US-20040137082-A1 Compounds and methods for reducing myostatin concentration PHOENIX LABORATORIES INC 2004-07-15 US disclosed
US-20040137083-A1 Method for making compounds for reducing myostatin concentration BIOTEST LABORATORIES 2004-07-15 US disclosed